Since our proposal of a dualistic model of epithelial ovarian carcinogenesis more than a
decade ago, a large number of molecular and histopathologic studies were published that …

Borderline ovarian tumors (BOT) are uncommon but not rare epithelial ovarian neoplasms,
intermediate between benign and malignant categories. Since BOT were first identified> 40 …

Simple Summary Historically, cancers presenting with their main tumor mass in the ovary
have been classified as ovarian carcinomas (a concise term for epithelial ovarian cancer) …

Four main histological subtypes of ovarian cancer exist: serous (the most frequent),
endometrioid, mucinous and clear cell; in each subtype, low and high grade. The large …

An accurate understanding of the clonal origins of tumors is critical for designing effective
strategies to treat or prevent cancer and for guiding the field of cancer risk assessment. The …

Inflammatory cytokines, like tumor necrosis factor–alpha (TNF-α) and interleukin-6 (IL-6), are
elevated in ovarian cancer. Differences in cytokine expression by histologic subytpe or …

The origin of primary mucinous ovarian tumors is unknown. We explore the hypothesis that
they originate from either Brenner tumors or teratomas and examine differences between the …

The dualistic classification of epithelial ovarian cancer (EOC) into “type I” and “type II” is
widely applied in the research setting; it is used as a convenient way of conceptualizing …

Brenner tumors (BTs) are surface-epithelial stromal cell tumors that are categorized by the
World Health Organization as benign, borderline, and malignant. Due to the rarity of BTs, the …

Simple Summary Primary retroperitoneal carcinomas are very rare tumors. Their
pathogenesis remains unknown but may be associated with that of ovarian carcinomas …